| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.470 | 47.832 | 64.420 | 57.497 | 59.850 | 60.413 | 58.810 | 53.765 | 52.928 | 51.200 |
| Total Income - EUR | 48.470 | 47.833 | 64.431 | 57.497 | 59.850 | 60.413 | 58.810 | 53.765 | 52.928 | 51.200 |
| Total Expenses - EUR | 28.375 | 25.196 | 23.904 | 27.839 | 24.374 | 38.505 | 43.039 | 30.355 | 32.327 | 33.926 |
| Gross Profit/Loss - EUR | 20.095 | 22.637 | 40.527 | 29.658 | 35.476 | 21.908 | 15.770 | 23.409 | 20.601 | 17.274 |
| Net Profit/Loss - EUR | 19.127 | 21.202 | 38.600 | 28.330 | 34.896 | 21.304 | 15.126 | 19.314 | 17.237 | 14.412 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Lotus Terapia Srl
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 19.807 | 23.134 | 39.227 | 30.829 | 64.270 | 47.812 | 19.320 | 17.487 | 17.285 | 14.644 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 6.533 | 6.409 | 4.627 | 4.642 | 4.677 | 1.104 | 3.037 |
| Cash | 19.807 | 23.134 | 39.227 | 24.297 | 57.862 | 43.185 | 14.678 | 12.809 | 16.181 | 11.607 |
| Shareholders Funds | 19.181 | 21.255 | 38.651 | 28.380 | 62.738 | 44.835 | 15.174 | 4.973 | 17.285 | 14.460 |
| Social Capital | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 | 40 |
| Debts | 626 | 1.879 | 576 | 2.449 | 1.532 | 2.978 | 4.146 | 12.513 | 0 | 184 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 5.0415 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Lotus Terapia Srl